Brainsway Ltd. BWAY 深 沪
等待开盘 09-23 09:30:00 美东时间
15.51
+0.040
+0.26%
华盛通- 最 高15.74
- 今 开15.47
- 成交量 11.45万股
- 最 低 15.20
- 昨 收 15.47
- 总市值 2.93亿
- 52周最高 17.00
- 市盈率 静 140.11
- 换手率 0.61%
- 52周最低 7.84
- 委 比 -93.72%
- 总股本 1890.18万
- 历史最高 17.00
- 量 比 1.13
- 振 幅 3.49%
- 历史最低 1.38
- 每 手 1
- 风险率 1.36%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BrainsWay rises as FDA clears accelerated Deep TMS protocol
BrainsWay (NASDAQ:BWAY) shares spiked on Tuesday after the U.S. FDA cleared an additional treatment protocol for the company’s Deep Transcranial Magnetic Stimulation system (Deep TMS), a therapy indic...
09-17 01:41
稳定币的技术原理与信任逻辑
稳定币是一种基于区块链技术的数字资产，通过锚定机制维持价格稳定，广泛应用于交易结算、跨境支付等领域。其技术原理包括链下资产抵押型、链上资产抵押型和算法稳定币，依赖智能合约实现自动化管理。信任逻辑基于透明机制、可靠储备与监管保障。当前面临监管技术、币值稳定和制度治理等挑战。未来，稳定币将向供应链金融、房地产代币化等场景拓展，监管环境趋严，技术创新加速，有望成为主流金融基础设施。
09-16 09:34
Bowman to Attend D.A. Davidson Industrials Conference in September
Bowman Consulting Group Ltd. announced its participation in D.A. Davidson’s 24th Annual Diversified Industrials & Services Conference, scheduled for September 17-19 at The Four Seasons Hotel in Nashville, Tennessee. Headquartered in Reston, Virginia, Bowman is a national engineering services firm with 2,500 employees and 100 locations across the U.S., offering infrastructure, technology, and project management solutions. For more information, vis...
08-26 11:30
BrainsWay Targets Expansion of its Total Addressable Market through a Strategic Investment in Neuromodulation Systems Developer, Neurolief Ltd.
BrainsWay has invested $5 million in Neurolief through a convertible loan and an option to acquire the company, supporting its development of an at-home neuromodulation platform for treating mental health disorders. Neurolief’s Proliv™Rx device, designed for treating resistant major depressive disorder (MDD) outside clinical settings, is pending FDA approval and could become the first FDA-cleared medical device for MDD treatment for home use. The...
08-21 11:30
BrainsWay Acquires Minority Stake in Axis Integrated Mental Health
The latest announcement is out from Brainsway ( ($BWAY) ). On August 20, 2025, ...
08-20 19:57
BrainsWay Invests $2.3M In Axis Mental Health Clinics With Option For $1M More
BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it has entered into a
08-20 19:38
美股大行评级 | 潜在涨幅仍有782.74%！Passage BIO遭Canaccord Genuity下调目标价至67美元，维持"买入"评级
今日重点评级关注：Northland Capital Markets：维持BrainsWay"跑赢大市"评级，目标价从15美元升至19美元；Lake Street：维持Hyperfine"买入"评级，目标价从1.5美元升至2美元
08-15 09:30
Breaking Down BrainsWay: 4 Analysts Share Their Views
Analysts' ratings for BrainsWay (NASDAQ:BWAY) over the last quarter vary from b...
08-15 03:01
HC Wainwright & Co. Maintains Buy on BrainsWay, Raises Price Target to $17
HC Wainwright & Co. analyst Raghuram Selvaraju maintains BrainsWay (NASDAQ:BWAY) with a Buy and raises the price target from $16 to $17.
08-14 19:24
BrainsWay Raises FY2025 Sales Guidance from $49.000M-$51.000M to $50.000M-$52.000M
BrainsWay (NASDAQ:BWAY) raises FY2025 sales outlook from $49.000 million-$51.000 million to $50.000 million-$52.000 million.
08-13 19:32
